直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Represented a company in compulsory license proceedings*

Advised and represented a pharmaceutical company in compulsory license proceedings before the Federal Patent Court.

Related Professionals

Dr. Antje Brambrink
Partner
Munich
+49 89 83931 1239
Email

Related Practices

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Related Industries

Life Sciences

Pharmaceutical

*Matter handled prior to joining Finnegan.

Related Experiences

Represented biopharmaceutical company in compulsory licensing proceedings*

Represented a telecommunications company in infringement proceedings*

Represented a renewable energy company in inspection proceedings*

Represented a communication technology company in patent litigation proceedings*

Represented information technology company in patent litigation proceedings*

Represented a renewable energy company in infringement and nullity proceedings*

Represented U.S. company in patent infringement and nullity proceedings concerning medical devices*

Represented medical device company in patent infringement proceedings and nullity proceedings*

Represented information technology company in patent infringement and nullity proceedings*

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP